Market Place
Sourcing Support
All News #Library
Biotech
Lexicon Pharma Announces 3 Posters at ACC Session
24 Mar 2026 //
GLOBENEWSWIRE
Lexicon, Novo Launch Oral LX9851 Phase 1 Obesity Trial
23 Mar 2026 //
GLOBENEWSWIRE
Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase
22 Jan 2026 //
BIOSPACE
Lexicon Pharma Gets Positive FDA EOP2 for Pilavapadin in DPN Pain
21 Jan 2026 //
GLOBENEWSWIRE
Lexicon Pharma: Data Bolster ACSL5`s Role in Endocrine Function
10 Dec 2025 //
GLOBENEWSWIRE
Sotagliflozin Benefits In Diverse Patients To Be Showcased
04 Nov 2025 //
GLOBENEWSWIRE
Lexicon Supports Ph III Go Decision for Non-Opioid Pain Med
18 Sep 2025 //
BIOSPACE
Lexicon Pharmaceuticals to Present at Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Sotagliflozin reduces hypoglycemia risk in Type 1 diabetes
23 Jun 2025 //
GLOBENEWSWIRE
Novo to license obesity drug from Lexicon in up to $1 B deal
29 Mar 2025 //
FIERCE BIOTECH
Lexicon Pharma to Present at Leerink Partners Global Conference
07 Mar 2025 //
GLOBENEWSWIRE
Sotagliflozin Efficacy & Safety for Type 1 Diabetes at ASNKD
05 Nov 2024 //
GLOBENEWSWIRE
Lexicon Presents Preclinical Data on Semaglutide- Weight Loss
04 Nov 2024 //
GLOBENEWSWIRE
Lexicon Reports FDA Advisory Committee Outcome for Zynquista™
31 Oct 2024 //
GLOBENEWSWIRE
nVNS Effective In Accelerating Air Force Pilot Training
10 Sep 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.